1Sato Y, Goto Y, Narita N, et al.Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment [J].Cancer Microenviron, 2009, 2 (suppl 1) :205-214.
2Niedzielska L, Niedzielski Z, Tkacz M, et al.Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer[J].J Physiol Pharmacol, 2009, 60(suppl 1): 65-71.
3Smits EL, Cools N, Lion E, et al.The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells [J].Cancer Immunol Immunother, 2010, 59 (1): 35-46.
4Yarovinsky F, Zhang D, Andersen JF, et al.TLR11 activation of dendritic cells by a protozoan profilin-like protein [J].Science, 2005, 308 (5728) :1626-1629.
5Hamm S, Rath S, Michel S, et al.Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists [J].J Immunotoxicol, 2009, 6 (4): 257-265.
6Smits EL, Ponsaerts P, Berneman ZN, et al.The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy[J].Oncologist, 2008, 13 (8): 859-875.
7Gorden KB, Gorski KS, Gibson SJ, et al.Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8 [J].J Immunol, 2005, 174 (3): 1259-1268.
8Lombardi V, Van Overtvelt L, Horiot S, et al. Human dendritic cells Stimulated Via TLR7 and TLR8 induce the sequential production of IL-10, IFN-γ, and IL-17A by naive CD4+T cells [J]. J Immunol, 2009,182(6):3372-3379.
9Diebold SS, Kaisho T, Hemmi H, et al.Innate antiviral responses by means of TLR7- mediated recognition of single-stranded RNA [J].Science, 2004, 303 (5663): 1529-1531.
10Gibson SJ, Lindh JM, Riter TR, et al.Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod [J].Cell Immunol, 2002, 218 (1-2): 74-86.
